Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. (Q48811779)
Jump to navigation
Jump to search
scientific article published on 27 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. |
scientific article published on 27 October 2011 |
Statements
1 reference
Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. (English)
1 reference
1 reference
Yukiko Kasahara
1 reference
Tomohiro Matsuyama
1 reference
David Stern
1 reference
Akihiko Taguchi
1 reference
27 October 2011
1 reference
1 reference
43
1 reference
2
1 reference
499-506
1 reference